Historically, large urban academic centres have conducted the majority of clinical trials, leading to such issues as ...

The conversation centred on the company’s latest developments and strategic direction in cancer therapies, with a particular ...

What trends did delegates notice, in terms of new modalities, technologies, and approaches? Precision, personalisation, and ...

Summit Pharma has revealed that a second pivotal trial of its Akeso-partnered PD-1xVEGF bispecific ivonescimab has failed to ...